IR Centers and Michigan Institute of Urology add third outpatient IR lab in Michigan

IR Centers and Michigan Institute of Urology are expanding their collaboration to a third interventional radiology lab in Southeast Michigan, adding capacity and bringing in Dr. Jeremy Handel, MD. The move is aimed at shortening wait times and expanding access to minimally invasive, image-guided treatments close to home.

Why it matters: - The expansion adds outpatient interventional radiology capacity in Southeast Michigan. - The third lab is designed to reduce wait times for patients seeking minimally invasive alternatives to surgery. - The program extends access to image-guided care in physician-led outpatient settings. - The collaboration supports treatment for conditions including benign prostatic hyperplasia, pelvic venous disorders, chronic pelvic pain, hemorrhoidal disease, and musculoskeletal conditions.

What happened: - IR Centers and Prostate Centers USA announced an expanded collaboration with Michigan Institute of Urology on July 6, 2026. - The partnership is adding a third outpatient interventional radiology lab in Michigan. - Board-certified interventional radiologist Jeremy Handel, MD, is joining the program. - The expanded operation builds on the IR Centers at MIU program already running in Troy.

The details: - The new lab increases procedural capacity across Southeast Michigan. - The program will continue using standardized, outcomes-driven clinical pathways. - The expanded model is intended to serve a larger patient population with highly standardized, data-driven IR pathways. - Dr. Handel has more than two decades of interventional radiology experience. - Dr. Handel is board certified in Vascular & Interventional Radiology and Diagnostic Radiology. - Dr. Handel completed his interventional radiology fellowship at the Cleveland Clinic. - Dr. Handel earned his medical degree at the University of Florida College of Medicine. - Dr. Handel is recognized in the region for embolization work and for diagnosing and treating complex pelvic venous conditions. - The program will keep emphasizing physician training, staff education, procedural standardization, radiation safety optimization, and real-time outcomes tracking. - IR Centers operates in more than 30 U.S. markets. - IR Centers describes itself as an integrated outpatient specialty care platform focused on interventional radiology services. - MIU says it is one of the oldest and largest multispecialty urology practices in Michigan, with more than 50 years of history. - MIU treats urologic conditions for men, women, and children across Southeast Michigan and supports an active clinical research program. - IR Centers lists more information on its website. - MIU lists more information on its website.

Between the lines: - The expansion signals continued demand for outpatient, minimally invasive procedures outside traditional hospital settings. - Adding capacity alone is not the point; the companies are tying growth to standardized workflows and outcomes tracking. - The emphasis on radiation safety and procedural standardization suggests the program is built to scale without losing clinical consistency. - Dr. Handel's addition also signals a push to deepen specialized expertise in embolization and pelvic venous care.

What's next: - The expanded program will keep growing access to image-guided therapies across Southeast Michigan. - IR Centers and MIU plan to continue scaling the collaboration through physician training, staff education, and outcomes monitoring. - The added capacity is expected to support ongoing demand for outpatient IR procedures.

The bottom line: - IR Centers and Michigan Institute of Urology are betting that more outpatient IR capacity, paired with standardized clinical pathways, will widen access to minimally invasive care in Michigan while keeping quality consistent.